Is there ample proof that Biogen’s new Alzheimer’s med Aduhelm is beneficial to patients, physicians and society beyond the existing...

FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...

European Medicines Agency grants Orphan Drug Designation to Saroglitazar Mg for the treatment of patients with Primary Biliary...

Understanding there’s nothing small about a small cell lung cancer diagnosis, Jazz Pharmaceuticals is collaborating with four major lung...

Have you ever imagined the possibility of using your smartphone with your brain? Like, being able to operate your device with your mind,...

Biogen’s decision to price its historic Alzheimer’s med Aduhelm at a mouthwatering $56,000 per year expectedly vexed lawmakers in...

With obesity prevalent, undertreated, and hugely misunderstood, Novo Nordisk has been attempting to revolutionize the field with...

The U.S. Food and Drug Administration on May 28, 2021 approved Lumakras (Sotorasib) as the first therapy for adult patients with...

Eli Lilly’s Covid-19 antibody bamlanivimab already lost its solo FDA authorization as viral variants emerged. Now, the company’s...

Americans appreciate their vaccine makers. Cases in point? Moderna and Pfizer leapfrogged into the top 10 favorite companies in the U.S....

While the worldwide sales rankings of Big Pharma’s blockbuster drugs typically feature the biggest names in the industry, new meds...

Health took center stage in 2020 and pharma marketers banked on it. Even as other marketers cut down on advertising budgets, pharma brand...

Just as pharma observers were bracing themselves for the brunt of renewed antitrust scrutiny around monumental Biopharma transactions,...

The global Covid-19 vaccine supply is on the verge of another major challenge, but this time from Moderna. The mRNA Biotech Company...

Pfizer was first to market in the U.S. with its BioNTech partnered Covid-19 vaccine, and by and large, it’s avoided the safety and supply...

The pharma sector rapidly took center stage when covid-19 caught the world off guard in 2020. As the year went on, drugmakers fought the...

In only a few weeks after Sanofi agreed to purchase Bioverativ to establish a foothold in hemophilia, the smaller company scored a...

After a difficult few days for the AstraZeneca Covid-19 vaccine rollout, the European Medicines Agency offered fresh support for the...

Cost watchdogs at England’s National Institute for Health and Care Excellence (NICE) have repeatedly been against drugmakers pricing over...

As pharma companies respond to the Covid-19 pandemic by producing vaccines and therapeutics, a lot of them are losing patent protection...